Melinda McGrath
Chief Executive Officer at AUSTRALIAN CLINICAL LABS LIMITED
Net worth: 5 M $ as of 29/04/2024
Profile
Melinda McGrath is the founder of Tasmanian Medical Laboratories.
She currently holds the position of Chief Executive Officer & Executive Director at Clinical Laboratories Pty Ltd., Australian Clinical Labs Ltd., and is a Director at Geneseq Biosciences.
Her former positions include Chief Executive Officer at QML Pathology, and Director at various hospitals and health services.
McGrath has an undergraduate degree from The University of Queensland and a graduate degree from Central Queensland University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/01/2024 | 2,923,331 ( 1.45% ) | 5 M $ | 29/04/2024 |
Melinda McGrath active positions
| Companies | Position | Start |
|---|---|---|
| AUSTRALIAN CLINICAL LABS LIMITED | Chief Executive Officer | 31/12/2014 |
Clinical Laboratories Pty Ltd.
 Clinical Laboratories Pty Ltd. Medical/Nursing ServicesHealth Services Clinical Laboratories Pty Ltd. engages in providing healthcare services. It offers test including biochemistry, cytology, diagnostics, immunology, microbiology, molecular, surgical skin audit program, and warfarin care. The company was founded in 2015 and is headquartered in Clayton, Australia. | Chief Executive Officer | 31/12/2014 |
| Geneseq Biosciences | Director/Board Member | - |
Former positions of Melinda McGrath
| Companies | Position | End |
|---|---|---|
QML Pathology
 QML Pathology Medical/Nursing ServicesHealth Services Part of Healius Ltd., QML Pathology is a clinical laboratory and pathology service based in Murarrie, Australia. QML has developed a range of Quality Improvement and Continuing Professional Development (QI & CPD) educational audits and resources. The Australian company is able to provide accurate and affordable cardiac monitoring services through their dedicated patient collection centres. QML Pathology offers medical information brochures to patients to learn more about medical conditions and their lab testing implications. The company was founded by James Duhig, Noel Gutteridge, and John McKechnie has been the CEO of the company since 2015. QML Pathology was acquired by Mayne Group Ltd. on September 29, 2002. | Chief Executive Officer | 31/12/2014 |
| Redcliffe Hospital | Director/Board Member | - |
| The Prince Charles Hospital | Director/Board Member | - |
| Royal Brisbane & Women’S Hospital | Director/Board Member | - |
| Ramsay Health Care Australia Pty Ltd. | Chief Executive Officer | - |
Training of Melinda McGrath
| The University of Queensland | Undergraduate Degree |
| Central Queensland University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AUSTRALIAN CLINICAL LABS LIMITED | Health Services |
| Private companies | 13 |
|---|---|
Clinical Laboratories Pty Ltd.
Clinical Laboratories Pty Ltd. Medical/Nursing ServicesHealth Services Clinical Laboratories Pty Ltd. engages in providing healthcare services. It offers test including biochemistry, cytology, diagnostics, immunology, microbiology, molecular, surgical skin audit program, and warfarin care. The company was founded in 2015 and is headquartered in Clayton, Australia. | Health Services |
QML Pathology
QML Pathology Medical/Nursing ServicesHealth Services Part of Healius Ltd., QML Pathology is a clinical laboratory and pathology service based in Murarrie, Australia. QML has developed a range of Quality Improvement and Continuing Professional Development (QI & CPD) educational audits and resources. The Australian company is able to provide accurate and affordable cardiac monitoring services through their dedicated patient collection centres. QML Pathology offers medical information brochures to patients to learn more about medical conditions and their lab testing implications. The company was founded by James Duhig, Noel Gutteridge, and John McKechnie has been the CEO of the company since 2015. QML Pathology was acquired by Mayne Group Ltd. on September 29, 2002. | Health Services |
| Tasmanian Medical Laboratories | |
| Buderim Private Hospital | |
| St Andrew'S War Memorial Hospital | |
| St Stephens Private Hospital | |
| Metro North Hospital & Health Service | Government |
| Caboolture Hospital Pty Ltd. | |
| Ramsay Health Care Australia Pty Ltd. | |
| Royal Brisbane & Women’S Hospital | |
| The Prince Charles Hospital | |
| Redcliffe Hospital | |
| Geneseq Biosciences |
- Stock Market
- Insiders
- Melinda McGrath
